| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
|---|---|---|
| Report Filing | 2025-10-14 | 2025-07-24 |
| Revenue | 427 | 621.3 |
| Cost of Revenue | 267.1 | 377.2 |
| Gross Profit | 160 | 244 |
| Operating Expenses | 281.4 | 426.6 |
| Research & Development | 10.83 | 16.52 |
| Selling, General and Administrative | 129.3 | 207.6 |
| Other Operating Expenses | 141.2 | 202.5 |
| Operating Income | -121.4 | -182.6 |
| Net Non-Operating Interest | -20.7 | -34.21 |
| Interest Income | 0.011 | 0 |
| Interest Expense | 20.71 | 34.21 |
| Equity & Other Income/(Expense) | 64.51 | -9.26 |
| Income Before Tax | -77.59 | -226.1 |
| Income Tax Expense | -2.1 | -2.01 |
| Income Attributable to Non-Controlling Interest | 0 | 0 |
| Net Income | -75.5 | -224.1 |
| Depreciation and Amortization | 12.94 | 0 |
| EBITDA | -108.5 | -182.6 |
| Earnings Per Share (EPS) | -4.36 | -20.69 |
| Diluted Earnings Per Share | -4.36 | -20.69 |
| Weighted Average Shares Outstanding | 56.25 | 0 |
| Diluted Weighted Average Shares Outstanding | 58.84 | 0 |
